Empfehlung
10,6
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
42.3
1 Insider, 435K $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | ADMA BIOLOGICS, INC. |
|---|---|
| Ticker | ADMA |
| CIK | 0001368514 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | ADMA BIOLOGICS, INC. |
Status
| Zuletzt geprüft | 2026-03-24 12:44:40.939142 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 15.16 | -227,400.00 | -36,3% | |
| 2026-03-16 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 15.16 | -90,960.00 | -14,5% | |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Officer, COO and SVP, Compliance | Open Market Sale | -10,096 | 15.63 | -157,800.48 | -25,2% | |
| 2026-03-06 | ELMS STEVE | Director | Open Market Purchase | 7,000 | 15.39 | 107,730.00 | +17,2% | |
| 2026-03-06 | ELMS STEVE | Director | Open Market Purchase | 7,000 | 15.39 | 107,730.00 | +17,2% | |
| 2026-03-05 | ELMS STEVE | Director | Open Market Purchase | 7,000 | 15.67 | 109,690.00 | +17,5% | |
| 2026-03-05 | ELMS STEVE | Director | Open Market Purchase | 7,000 | 15.67 | 109,690.00 | +17,5% | |
| 2026-02-17 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 16.08 | -241,200.00 | -38,5% | |
| 2026-02-17 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 16.08 | -96,480.00 | -15,4% | |
| 2025-12-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 19.79 | -118,740.00 | -18,9% | |
| 2025-12-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 19.79 | -296,850.00 | -47,4% | |
| 2025-11-19 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 16.00 | -240,000.00 | -38,3% | |
| 2025-11-19 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 16.00 | -96,000.00 | -15,3% | |
| 2025-10-24 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 16.00 | -96,000.00 | -15,3% | |
| 2025-10-24 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 16.00 | -240,000.00 | -38,3% | |
| 2025-09-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 16.13 | -96,780.00 | -15,4% | |
| 2025-09-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 16.13 | -241,950.00 | -38,6% | |
| 2025-08-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 16.88 | -253,200.00 | -40,4% | |
| 2025-08-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 16.88 | -101,280.00 | -16,2% | |
| 2025-07-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 18.66 | -111,960.00 | -17,9% | |
| 2025-07-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 18.66 | -279,900.00 | -44,7% | |
| 2025-06-16 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 20.81 | -312,150.00 | -49,8% | |
| 2025-06-16 | ELMS STEVE | Director | Open Market Sale | -194,749 | 20.24 | -3,941,719.76 | -628,9% | |
| 2025-06-16 | ELMS STEVE | Director | Open Market Sale | -194,749 | 20.24 | -3,941,719.76 | -628,9% | |
| 2025-06-16 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 20.81 | -124,860.00 | -19,9% | |
| 2025-06-13 | ELMS STEVE | Director | Open Market Sale | -137,931 | 20.82 | -2,871,723.42 | -458,2% | |
| 2025-06-13 | ELMS STEVE | Director | Open Market Sale | -137,931 | 20.82 | -2,871,723.42 | -458,2% | |
| 2025-06-12 | ELMS STEVE | Director | Open Market Sale | -92,941 | 21.69 | -2,015,890.29 | -321,6% | |
| 2025-06-12 | ELMS STEVE | Director | Open Market Sale | -92,941 | 21.69 | -2,015,890.29 | -321,6% | |
| 2025-06-09 | Guiheen Lawrence P. | Director | Open Market Sale | -20,000 | 20.96 | -419,200.00 | -66,9% | |
| 2025-06-09 | Grossman Jerrold B | Director | Open Market Sale | -10,000 | 21.31 | -213,100.00 | -34,0% | |
| 2025-05-22 | Guiheen Lawrence P. | Director | Open Market Sale | -1,221 | 20.12 | -24,566.52 | -3,9% | |
| 2025-05-21 | Guiheen Lawrence P. | Director | Open Market Sale | -7,779 | 20.32 | -158,069.28 | -25,2% | |
| 2025-05-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 19.45 | -291,750.00 | -46,5% | |
| 2025-05-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 19.45 | -116,700.00 | -18,6% | |
| 2025-04-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15,000 | 21.46 | -321,900.00 | -51,4% | |
| 2025-04-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6,000 | 21.46 | -128,760.00 | -20,5% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.